Aggregate Asset Value: GRI Bio Inc (GRI)
GRI Bio, Inc. (GRI) develops methods for managing natural immunity to combat fibrosis, while sharing research costs with partners ensures balance sheet stability and future cash flow. The production process utilizes automated cell systems to eliminate human error. This chart reflects the current market value of total assets at 8.53. GRI Bio, Inc. (GRI) is expanding its own drug portfolio without mergers.
Financial and market metric breakdowns for GRI Bio Corp (GRI)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Analysis of all company metrics:GRI Bio, Inc.
When assessing the potential of GRI Bio, Inc. (GRI), investors analyze the aggregate resource base, which is reverse-calculated here via return on assets (ROA) to determine the total value of assets and liabilities. The trend in total asset value allows for the elimination of calculation anomalies, confirming capitalization stability under US biopharmaceutical legal protections, which minimizes geopolitical risks and strengthens the issuer's fundamental attractiveness.
Competitor analysis for GRI Bio, Inc.
argenx.com (ARGX) - Total Asset Value of Company|BNTX - Company Total Assets|Aggregate Asset Value Abivax|Company Total Assets ADMA|Company Total Assets PTGX (Protagonist Corp)|Aggregate Company Assets Immunovant, Inc.|kiniksa.com - Aggregate Asset Value|GRFS: Aggregate Company Assets|ADPT - Cumulative Company Assets|CLDX: Company Total Assets|Company Total Assets Aurinia Corp|BCRX - Cumulative Company Assets|Aggregate Asset Value veratx.com|DNTH (Dianthus Therapeutics, Inc.) - Company Total Assets|Company Total Asset Base PHVS (Pharvaris NV)|abcellera.com - Aggregate Company Assets|Tourmaline - Cumulative Company Assets|PGEN: Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio, Inc.) - Company Total Assets|Aggregate Company Assets Zenas Biopharma, Inc. (ZBIO)|Total Business Assets Immunome Bio|Gossamer Bio, Inc. - Company Total Assets|Company Assets kalvista.com (KALV)|SEPN (Septerna) - Company Total Assets|Pieris Pharma - Company Balance Sheet Assets|Aggregate Company Assets Savara Corp (SVRA)|RIGL - Aggregate Asset Value|AnaptysBio, Inc. - Company Total Assets|Company Total Asset Base astriatx.com|ENGN - Cumulative Company Assets|Aggregate Asset Value RAPT Therapeutics Inc.|Company Total Assets Aerovate Therapeutics Inc (JBIO)|Aggregate Company Assets Aclaris Therapeutics, Inc (ACRS)|Company Total Assets KYTX|tizianalifesciences.com - Company Total Asset Base|CABA (Cabaletta Bio) - Aggregate Company Assets|Ventyx Biosciences Inc. (VTYX) - Company Assets|Cumulative Company Assets Theratechnologies Inc THTX|Avalo Therapeutics Inc (AVTX) - Aggregate Asset Value|ELDN: Company Total Assets|Company Total Asset Base AGEN|Aggregate Company Assets Climb Bio CLYM|Total Business Assets Zura Bio Ltd (ZURA)|aTyr - Company Total Assets|ADAG - Cumulative Company Assets|Cumulative Company Assets IMA (Ikena Oncology, Inc.)|STTK - Company Total Asset Base|Company Total Assets EQ (equilliumbio.com)|CNTB (Connect Biopharma Holdings Limited) - Company Balance Sheet Assets|IMUX - Aggregate Company Assets|Aggregate Asset Value Atara Biotherapeutics Inc|IFRX (InflaRx N.V.) - Company Total Assets|Company Total Asset Base XFOR (x4pharma.com)|Adicet Bio, Inc. (ACET) - Aggregate Company Assets|Total Asset Value of Company Celularity Inc CELU|Company Total Assets INmune Bio Corp (INMB)|BRNS - Aggregate Asset Value|KZR: Company Total Assets|SABS (sabbiotherapeutics.com) - Company Total Assets|AKTX - Aggregate Company Assets|Aggregate Asset Value ENLV|Aggregate Company Assets QTTB (Q32 Bio Inc.)|Cumulative Company Assets GeoVax Corp (GOVX)|Company Total Assets EDSA (Edesa Biotech, Inc.)|IBIO - Company Total Assets|Cumulative Company Assets Carisma Tx (CARM)|XTLB - Aggregate Asset Value|boltbio.com - Company Total Assets|HCWB (HCW Biologics) - Company Total Asset Base|Aggregate Company Assets APVO|Cumulative Company Assets AIM|Aggregate Company Assets ADTX (Aditxt)|Cumulative Company Assets XORTX Therapeutics Inc XRTX|Cumulative Company Assets HIND (ReShape Lifesciences)|Revelation Biosciences Corp - Company Total Assets|Indaptus Therapeutics (INDP) - Aggregate Company Assets|SCNI - Total Business Assets|Company Total Assets CALI|Affimed N.V. (AFMD) - Company Assets|Allakos Inc - Company Total Assets|Company Balance Sheet Assets HOOK|IGM Biosciences, Inc. (IGMS) - Aggregate Company Assets|Aggregate Asset Value iteostherapeutics.com (ITOS)|Company Total Assets OCEA|TCBP - Company Total Asset Base|Cumulative Company Assets Third Harmonic Bio, Inc (THRD)